ENSIGN GROUP, INC vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ENSG and FMS diverge most: on dividend yield, ENSG reads 0.1% and FMS reads 1.9%; on revenue growth, ENSG reads +18.9% and FMS reads +1.5%. The rest of the comparable metrics sit closer together. What ENSG's price implies is a bet that sits within the historical range (whole-company basis). What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | ENSG | FMS |
|---|---|---|
| Price | $171.79 | $21.05 |
| Market cap | $10.0B | $12.3B |
| Sector | Medical Care | Medical Care |
| Stage | Growth | Mature |
| Implied growth (priced in) | +7.0% | — |
| P/E | 26.9 | 11.5 |
| P/B | 4.09 | 0.79 |
| P/S | 1.82 | 0.58 |
| EV/EBITDA | 17.0 | 5.2 |
| Revenue growth | +18.9% | +1.5% |
| Operating margin | 8.5% | 11.7% |
| Net margin | 6.9% | 6.1% |
| Return on equity | 15.5% | 8.3% |
| Return on assets | 6.6% | 3.8% |
| Return on invested capital | 13.5% | 6.7% |
| FCF yield | 6.1% | 23.7% |
| Dividend yield | 0.1% | 1.9% |
| Debt / equity | 0.06 | 0.51 |
| Current ratio | 1.21 | 1.26 |
| Altman Z (solvency) | 3.36 | 1.72 |
| Piotroski F (quality) | 8 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.